1. Home
  2. TRIB vs TOVX Comparison

TRIB vs TOVX Comparison

Compare TRIB & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRIB
  • TOVX
  • Stock Information
  • Founded
  • TRIB 1992
  • TOVX 2001
  • Country
  • TRIB Ireland
  • TOVX United States
  • Employees
  • TRIB N/A
  • TOVX N/A
  • Industry
  • TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • TOVX Biotechnology: Pharmaceutical Preparations
  • Sector
  • TRIB Health Care
  • TOVX Health Care
  • Exchange
  • TRIB Nasdaq
  • TOVX Nasdaq
  • Market Cap
  • TRIB 5.4M
  • TOVX 4.5M
  • IPO Year
  • TRIB N/A
  • TOVX 2006
  • Fundamental
  • Price
  • TRIB $1.20
  • TOVX $0.41
  • Analyst Decision
  • TRIB
  • TOVX Hold
  • Analyst Count
  • TRIB 0
  • TOVX 1
  • Target Price
  • TRIB N/A
  • TOVX N/A
  • AVG Volume (30 Days)
  • TRIB 2.4M
  • TOVX 359.6K
  • Earning Date
  • TRIB 11-14-2025
  • TOVX 11-11-2025
  • Dividend Yield
  • TRIB N/A
  • TOVX N/A
  • EPS Growth
  • TRIB N/A
  • TOVX N/A
  • EPS
  • TRIB N/A
  • TOVX N/A
  • Revenue
  • TRIB $61,555,000.00
  • TOVX N/A
  • Revenue This Year
  • TRIB $13.51
  • TOVX N/A
  • Revenue Next Year
  • TRIB $13.14
  • TOVX N/A
  • P/E Ratio
  • TRIB N/A
  • TOVX N/A
  • Revenue Growth
  • TRIB 8.31
  • TOVX N/A
  • 52 Week Low
  • TRIB $0.48
  • TOVX $0.37
  • 52 Week High
  • TRIB $3.44
  • TOVX $4.20
  • Technical
  • Relative Strength Index (RSI)
  • TRIB 49.30
  • TOVX 48.50
  • Support Level
  • TRIB $1.42
  • TOVX $0.38
  • Resistance Level
  • TRIB $1.28
  • TOVX $0.44
  • Average True Range (ATR)
  • TRIB 0.09
  • TOVX 0.02
  • MACD
  • TRIB -0.03
  • TOVX 0.00
  • Stochastic Oscillator
  • TRIB 26.67
  • TOVX 51.29

About TRIB Trinity Biotech plc

Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Share on Social Networks: